ESG

Sensus Healthcare's new Sensus Link software aims to upgrade existing skin cancer treatment systems, signaling a major strategic shift to the cloud.

Banuba's new AI Talking Photo API promises to revolutionize video creation, but the rise of lifelike digital avatars also fuels a critical ethical debate.

New Energy New York is injecting capital into battery startups and SMEs to accelerate innovation and reshore manufacturing, a key move for U.S. energy security.

With promising data for its oral STAT6 degrader and a cash runway into 2029, Kymera Therapeutics is poised to disrupt the injectable-dominated market.

Kairos Pharma aims to reshape lung cancer treatment by acquiring two AI-designed drugs, targeting a key resistance mechanism in a multi-billion dollar market.

Vistra posts record 2025 results and a bullish 2026 forecast, fueled by major acquisitions and landmark nuclear power deals with tech titans AWS and Meta.

With record SUBLOCADE revenue and a new U.S. home, Indivior launches a $400M buyback, signaling a new era in its fight against the opioid crisis.

With soaring sales for its rare obesity drug IMCIVREE, Rhythm Pharmaceuticals faces a critical March FDA decision that could unlock a massive new market.

New analyses of Upstream Bio's verekitug aim to prove its true effectiveness for nasal polyps, setting the stage for a competitive showdown.

Kolibri Global Energy Inc. just released its first sustainability report. Is it a genuine shift or a strategic play in a world demanding greener energy?

A new collaboration is betting on tiny natural particles to deliver a gene-editing cure for a devastating neurological disorder, bypassing a key medical hurdle.

Eos Energy reports record revenue and a fortified balance sheet, resolving 'going concern' doubts, but sets 2026 guidance below analyst expectations.

Montréal startup JetScale AI lands an oversubscribed seed round for its AI platform that slashes cloud spending and energy waste in just minutes.

Techem's new sustainability report reveals an 11.2% CO2e drop, a major digital rollout with 85% smart devices, and new e-mobility and circular economy goals.

A novel mouse model with human immune receptors promises to slash the high failure rate of antibody therapies, accelerating life-saving treatments.

Fourth iQ 3.0 launches with above-store AI, promising executives a new way to fight rising costs, boost profits, and manage sprawling restaurant empires.

ASUS unveils new liquid-cooling solutions and a partner ecosystem to combat the intense heat of next-gen AI, promising a more sustainable, powerful future.

Vista Gold Corp. launches a major public offering to advance its massive Mt. Todd gold project in Australia, testing investor appetite for junior miners.

After a year focused on organic growth, the environmental firm posted record results and now plans a disciplined return to acquisitions in 2026.

Pennant Group posts record revenue and an aggressive 2026 outlook, but rapid expansion and regulatory headwinds present a complex path forward for the provider.